Chemopreventive effect of plant originated glycoprotein on colitis-mediated colorectal cancer in A/J mice

Journal of Biomedical Science

Volumn 15, Issue 1, 2008, Pages 111-121

  Lee, Sei Jung ^a   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

Activator protein 1; Colorectal cancer; Inflammation related factors; Nuclear factor kappa B; UDN glycoprotein

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CYCLINE; CYCLOOXYGENASE 2; DEXTRAN; DEXTRAN SODIUM SULFATE; GLYCOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; ULMUS DAVIDIANA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLITIS; COLON; COLORECTAL CANCER; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME BLOOD LEVEL; FOOD INTAKE; GENE ACTIVITY; GENE INACTIVATION; MALE; MOUSE; NONHUMAN; PLANT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; SERUM; ULMUS DAVIDIANA;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; COLITIS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DNA PRIMERS; GENE EXPRESSION; GLYCOPROTEINS; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

MUS; ULMUS DAVIDIANA;

EID: 36749001714     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9196-9     Document Type: Article

References (32)

1. Itzkowitz S.H., Yio X., Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G7-G17, 2004
2. Ohshima H., Tazawa H. Sylla B.S., Sawa T., Prevention of human cancer by modulation of chronic inflammatory processes. Mutat. Res. 591: 110-122, 2005
3. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990
4. Whiteley L.O., Hudson L. Jr., Pretlow T.P., Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol. Pathol. 24: 681-689, 1996
5. Swenberg J.A., Cooper H.K., Bucchler J., Kleihues P., 1,2-Dimethylhydrazine-induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. Cancer Res. 39: 465-467, 1979
6. Fiala E.S., Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine and azoxymethane. Cancer 40: 2436-2445, 1977
7. Wang J.G., Wang D.F., Lv B.J., Si J.M., A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium. World J. Gastroenterol. 10: 2958-2962, 2004
8. Onose J., Imai T., Hasumura M., Ueda M., Hirose M., Rapid induction of colorectal tumors in rats initiated with 1,2-dimethylhydrazine followed by dextran sodium sulfate treatment. Cancer Lett. 198: 145-152, 2003
9. Kohno H., Suzuki R., Sugie S., Tanaka T., Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate. Cancer Sci. 96: 69-76, 2005
10. Ooi V.E., Liu F., Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 7: 715-729, 2000
11. Searcey M., Patterson L.H., Resistance in cancer: a target for drug discovery. Curr. Med. Chem. Anti-Canc. Agents 4: 457-460, 2004
12. Lind D.S., Hochwald S.N., Malaty J., Rekkas S., Hebig P., Mishra G., Moldawer L.L., Copeland E.M., MacKay S., Nuclear factor-kB is upregulated in colorectal cancer. Surgery 130: 363-369, 2001
13. Lee S.J., Lim K.T., Glycoprotein isolated from Ulmus davidiana Nakai regulates expression of iNOS and COX-2 in vivo and in vitro. Food Chem. Toxicol. 45: 990-1000, 2007
14. Bergmeyer H.U., Bernt E., Lactate dehydrogenase. In: Bergmeyer H.U. (Ed.), Methods of Enzymatic Analysis, Academic Press, New York, 1974, pp. 574-579
15. Buege J.A., Aust S.D., Microsomal lipid peroxidation. Methods Enzymol. 52: 302-310, 1978
16. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R., Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 126: 131-138, 1982
17. Naziroglu M., Cay M., Ustundag B., Aksakal M., Yekeler H., Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem. Funct. 17: 253-259, 1999
18. Shin D.M., Voravud N., Ro J.Y., Lee J.S., Hong W.K., Hittelman W.N., Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst. 85: 971-978, 1993
19. Subapriya R., Kumaraguruparan R., Nagini S., Expression of PCNA, cytokeratin, Bcl-2 and p53 during chemoprevention of hamster buccal pouch carcinogenesis by ethanolic neem (Azadirachta indica) leaf extract. Clin. Biochem. 39: 1080-1087, 2006
20. Seril D.N., Liao J., Yang G.Y., Yang C.S., Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24: 353-362, 2003
21. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481: 243-268, 2001
22. Bachschmid M., Schildknecht S., Ullrich V., Redox regulation of vascular prostanoid synthesis by the nitric oxide-superoxide system. Biochem. Biophys. Res. Commun. 338: 536-542, 2005
23. Hill K.A., Wang K.L., Stryker S.J., Gupta R., Weinrach D.M., Rao M.S., Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer. Oncol. Rep. 11: 951-956, 2004
24. Hinz B., Brune K., Cyclooxygenase-2-10 years later. J. Pharmacol. Exp. Ther. 300: 367-375, 2002
25. Barnes P.J., Karin M., Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071, 1997
26. Schreiber S., Nikolaus S., Hampe J., Activation of nuclear factor kappa B in inflammatory bowel disease. Gut, 42: 477-484, 1998
27. Ledebur H.C., Parks T.P., Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 270: 933-943, 1995
28. Kouzarides T., Ziff E., The role of the leucine zipper in the fos-jun interaction. Nature 336: 646-651, 1988
29. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow. Lancet 357: 539-545, 2001
30. Coussens L.M., Werb Z., Inflammation and cancer, Nature 420: 860-867, 2002
31. Scheller J., Ohnesorge N., Rose-John S., Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand. J. Immunol. 63: 321-329, 2006
32. Kanakaraj P., Schafer P.H., Cavender D.E., Wu Y., Ngo K., Grealish P.F., Wadsworth S.A., Peterson P.A., Siekierka J.J., Harris C.A., Fung-Leung W.P., Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J. Exp. Med. 187: 2073-2079, 1998